{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:01:08Z","timestamp":1792839668088,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/ajg.2015.283","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T08:04:11Z","timestamp":1441699451000},"page":"1450-1459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Persistent Liver Biochemistry Abnormalities Are More Common in Older Patients and those With Cholestatic Drug Induced Liver Injury"],"prefix":"10.14309","volume":"110","author":[{"given":"Robert J","family":"Fontana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiman","family":"Barnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajender K","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Stolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210210","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"key":"R2-16-20210210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2014.03.045","article-title":"Idiosyncratic drug induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.","volume":"147","author":"Fontana","year":"2014","journal-title":"Gastroenterology"},{"key":"R3-16-20210210","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"R4-16-20210210","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.44.5.731","article-title":"The natural history of histologically proved drug-induced liver disease.","volume":"44","author":"Aithal","year":"1999","journal-title":"Gut"},{"key":"R5-16-20210210","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.21424","article-title":"Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry.","volume":"44","author":"Andrade","year":"2006","journal-title":"Hepatology"},{"key":"R6-16-20210210","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jhep.2008.10.021","article-title":"The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice.","volume":"50","author":"Bjornsson","year":"2009","journal-title":"J Hepatol"},{"key":"R7-16-20210210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2036.2007.03355.x","article-title":"Long-term follow-up of patients with mild to moderate drug-induced liver injury.","volume":"26","author":"Bjornosson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-16-20210210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","article-title":"Drug-induced liver injury network (DILIN) prospective study: rationale, design and conduct.","volume":"32","author":"Fontana","year":"2009","journal-title":"Drug Saf"},{"key":"R9-16-20210210","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/hep.23577","article-title":"Rochon J et al. for the US DILIN. Causality assessment in drug induced liver injury using a structured expert opinion process: comparison to RUCAM.","volume":"51","author":"Rockey","year":"2010","journal-title":"Hepatology"},{"key":"R10-16-20210210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.510300203","article-title":"Health-related quality of life in chronic hepatitis C: impact of disease and treatment response.","volume":"30","author":"Ware","year":"1999","journal-title":"Hepatology"},{"key":"R11-16-20210210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-Induced liver injury: systematic evaluation and clinical associations.","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"key":"R12-16-20210210","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"R13-16-20210210","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity.","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"R14-16-20210210","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/liv.12632","article-title":"2-year outcomes in initial survivors with acute liver failure: results from a prospective, multicenter study.","volume":"35","author":"Fontana","year":"2014","journal-title":"Liver Int"},{"key":"R15-16-20210210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/jhep.2000.8169","article-title":"Low frequency of cirrhosis in a hepatitis C (genotype 1b) single source outbreak in Germany: a 20 year multicenter study.","volume":"32","author":"Wiese","year":"2000","journal-title":"Hepatology"},{"key":"R16-16-20210210","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/jhep.2001.21905","article-title":"Long-term morbidity and mortality of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood institute Collaborative Study.","volume":"33","author":"Seeff","year":"2001","journal-title":"Hepatology"},{"key":"R17-16-20210210","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index.","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"key":"R18-16-20210210","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/lt.23469","article-title":"Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey.","volume":"18","author":"Yamasahiki","year":"2012","journal-title":"Liver Transpl"},{"key":"R19-16-20210210","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/hep.26099","article-title":"Aging promotes the development of diet induced murine steatohepatitis but not steatosis.","volume":"57","author":"Fontana","year":"2013","journal-title":"Hepatology"},{"key":"R20-16-20210210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1089-3261(03)00032-1","article-title":"Drug-induced cholestasis.","volume":"7","author":"Levy","year":"2003","journal-title":"Clin Liv Dis"},{"key":"R21-16-20210210","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.1840200610","article-title":"Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis.","volume":"20","author":"Mandapoor","year":"1994","journal-title":"Hepatology"},{"key":"R22-16-20210210","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0168-8278(05)80476-3","article-title":"Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis.","volume":"20","author":"Davies","year":"1994","journal-title":"J Hepatol"},{"key":"R23-16-20210210","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1053\/hupa.2002.128060","article-title":"Destruction of canals of hering in primary biliary cirrhosis.","volume":"33","author":"Saxena","year":"2002","journal-title":"Hum Pathol"},{"key":"R24-16-20210210","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/hep.26020","article-title":"Keratin 19 demonstration of canal of Hering loss in primary biliary cirrhosis: minimal change PBC?","volume":"57","author":"Khan","year":"2013","journal-title":"Hepatology"},{"key":"R25-16-20210210","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.24613","article-title":"Ductular reactions in human liver: diversity at the interface.","volume":"54","author":"Gouw","year":"2011","journal-title":"Hepatology"},{"key":"R26-16-20210210","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/jhep.2003.09022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C.","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"R27-16-20210210","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"key":"R28-16-20210210","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis.","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2015283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2015283","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2015283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201510000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:10:28Z","timestamp":1786547428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201510000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2015.283","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}